| Aug 14 |
Trinity Biotech Announces Q2 2024 Financial Results
|
| Aug 13 |
Trinity Biotech to Announce Q2 2024 Financial Results
|
| Aug 6 |
Trinity Biotech obtains extension to demonstrate compliance with Nasdaq listing requirements
|
| Aug 6 |
Trinity Biotech Obtains an Extension to Demonstrate Compliance With Nasdaq Listing Requirements
|
| Aug 2 |
Trinity Biotech Provides Preliminary Second Quarter 2024 Update and Enters into UK Distribution Agreement with MedScience
|
| Jul 9 |
Trinity Biotech names Louise Tallon as CFO
|
| Jul 9 |
Trinity Biotech Announces Appointment of A New CFO
|
| Jun 24 |
Trinity Biotech to Begin European Pre-Pivotal Trial to Optimize its CGM Sensor
|
| Jun 21 |
Trinity Biotech files for $50M mixed shelf offering
|
| Jun 3 |
Trinity Biotech Launches its Continuous Glucose Monitoring Microsite to Showcase its Innovative & Differentiated Technology
|
